Skip to main content

Approaches to enhance the efficacy of immunotherapies

24 Sep 2024
Translational Research
  • Discuss the translational challenges, including heterogeneity within the TME, off-target effects, and potential autoimmune toxicities.
  • What are the available innovative preclinical models, biomarker discovery platforms.
  • Where do we stand on rapid screening to choose appropriate immunotherapies using patients derived organoids (PDOs).
  • Clinical trial designs to accelerate the translation of promising immunotherapies from bench to bedside.
Industry Expert
Hemant Mishra, Director - Cellinfinity